Global Lidocaine Market is valued at approximately USD 893.23 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2020-2027. Lidocaine, also referred to as lignocaine, is a provincial anesthetic of the amino amide type. Lidocaine helps to reduce sharp burning pains as well as discomfort caused by skin irritations such as scratches, poison sumac, poison ivy, minor cuts, poison oak, insect bites, and sunburns. Further, lidocaine's local painkiller action foresees its use in extensive medicinal circumstances or situations that may benefit from its action, involving the treatment of impulsive ejaculation, which may reinforce the demand for lidocaine market all over the world. Also, it is frequently used in dental procedure and cosmetic surgery, for laser resurfacing after 20 minutes without occlusion. Thus, rising cosmetic surgical procedures has increased the demand for lidocaine which is primarily drives the growth of the market. For instance: as per the Victorian Cosmetic Institute, the total number of cosmetic surgical procedures in Australia estimated at around 1,790,832 in 2017 and is increased to nearly 1,811,740 in 2018. Similarly, as of 2018, nearly 53,028 Australian had done neck lifting surgery and has risen to 53,571 number of people undergone through neck lifting surgical procedure in 2019. Moreover, Lidocaine is commonly used for its anti-inflammatory actions to reduce cough and improve respiratory symptoms in severe asthmatic patients. Thus, increasing cases of chronic disease, followed by the rising geriatric population resulting in encouraging the demand for lidocaine; therefore, propelling the growth of the market. According to National Center for Biotechnology Information, generally, 33% of Chinese and 49% of Indian respondents aged 50 and older reported at least one chronic condition. As per Statista, the number of people with asthma in Australia were 2013.5 thousand people in 2005 and has risen to 2705.1 thousand peoples suffering from asthma in 2018. This, in turn, is likely to strengthen the demand for Lidocaine, thereby contributing to the market growth around the world. However, the strict regulatory standards for lidocaine is one of the prime factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Lidocaine market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing demand for lidocaine formulations, along with the wide presence of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in number of cometic procedures and dental procedures coupled with increasing awareness regarding lidocaine among medical practitioners in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Lidocaine market in the Asia-Pacific region.

Major market player included in this report are:
Amneal Pharmaceuticals Inc.
AstraZeneca
Teligent
Centura Pharmaceuticals
Taro Pharmaceutical Industries Ltd.
Pfizer Inc.
Merck KGaA
SCILEX Pharmaceuticals, Inc.
Mahendra chemicals
Cirondrugs

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Powder
Gel
Cream

By Application:
Cosmetics
Medicine

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027

Target Audience of the Global Lidocaine Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors